Latest Conference Articles

Catch up on coverage from the first day of the 2026 American Academy of Dermatology Annual Meeting held in Denver, Colorado.

Nicole Negbenebor, MD, highlights the clinical and professional impact of community-driven education and evidence-based focus in skin of color dermatology.

Christopher Bunick, MD, PhD, interviews medical student Sabine Obagi on the value of conference participation, mentorship, and early exposure for aspiring dermatology clinicians at AAD 2026.

Melanoma cases keep rising, but AI-aided screening, gene profiling, and newer immunotherapies boost early diagnosis and long-term survival, according to Darrell Rigel, MD, MS.

This year’s AAD poster awards highlight studies advancing skin cancer prevention, inflammatory disease management, and complex dermatology care.

BE HEARD extension data underscore the importance of early diagnosis and treatment initiation to optimize long-term outcomes in hidradenitis suppurativa.

With 80% of trial participants being children, this analysis provides some of the most robust early-response data available for a non-steroidal topical in pediatric AD.

Read more on how to navigate all the opportunities at this year’s AAD meeting, which starts today in Denver, Colorado.

At the pre-AAD meeting, Regina Benjamin, MD, MBA, discussed the role of clinicians as leaders in addressing social determinants of health, emphasizing prevention, education, and culturally responsive care.

Targeted therapies are increasingly used earlier in treatment rather than being reserved for severe or refractory cases.

Overall, the future of dermatology lies in integrating innovation with individualized, evidence-based, and patient-centered care.

PANP360 Immersive will deliver one-day, high-yield dermatology CME for NPs and PAs, featuring hands-on workshops, complex case strategies, and practical tips to optimize therapies.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Omar Noor, MD, FAAD, discusses strategies to improve psoriasis care for patients facing adherence challenges related to lifestyle or cognitive barriers.

Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, reviewed clinical trial and long-term data supporting biologic therapies for HS, emphasizing individualized patient selection and timing of intervention.

Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed clinical cases highlighting the distinct roles of topical ruxolitinib, tapinarof, and roflumilast in managing itch, inflammation, and long-term disease control in atopic dermatitis.

Douglas DiRuggiero, DMSc, MHS, PA-C, emphasized that relying solely on body surface area underestimates psoriasis burden, particularly for patients with disease in high-impact or special areas.

Catch up on coverage from this year's Winter Clinical Miami meeting.

Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, highlighted that CHE is often mischaracterized and frequently involves overlapping subtypes.

At Winter Clinical Miami 2026, Andrew F. Alexis, MD, MPH, shares skin-of-color therapy pearls as Clay Cockerell, MD, spotlights must-biopsy mimickers.

Winter Clinical Miami experts shared professional development tips and clinical pearls during the meeting's classic "15 Tips in 15 Minutes" session.

Omar Noor, MD, shares pearls on type 2 inflammation, including dupilumab insights for atopic dermatitis, prurigo nodularis, and CSU at Horizons in Advanced Practice.

Nicholas Brownstone, MD, and other experts spotlighted cytokine hubs at the 2026 Winter Clinical Miami conference, linking chronic spontaneous urticaria and psoriasis/psoriatic arthritis to smarter targeted treatment choices.

Explore top dermatology conferences and meetings in March 2026 and let us know which ones you'll be attending!

CLEAR CSCC is evaluating whether low-dose intralesional cemiplimab is noninferior to primary surgery, potentially offering a tissue-sparing alternative to standard surgical management.

Brian Berman, MD, PhD, explains actinic keratosis-to-SCC risk and newer PDT/field therapies that improve clearance with less pain.

Ruiz Dasilva emphasized case-based strategies for managing complex inflammatory dermatoses, highlighted chronic pruritus as an urgent unmet need, and called for more standardized designs for atopic dermatitis trials.

Terrence Keaney, MD, and Dawn Merritt, DO, discuss AI workflows and smart practice systems—plus how a dermatology niche drives referrals and growth.